Literature DB >> 27670359

Low oxygen saturation and severe anemia in compound heterozygous Hb Louisville [β42(CD1)Phe→Leu] and Hb La Desirade [β129(H7)Ala→Val].

Parin Kamseng1, Satariya Trakulsrichai2,3, Objoon Trachoo4,5, Walaiporn Yimniam1, Bhakbhoom Panthan1,5, Paisan Jittorntam6, Pimjai Niparuck4, Pitsucha Sanguanwit2, Winai Wananukul3,4, Sumalee Jindadamrongwech1.   

Abstract

OBJECTIVE: To investigate the cause(s) of a Thai male proband presenting low oxygen saturation by pulse oximetry (SpO2) and severe anemia.
METHODS: As Hb variant was suspected, Hb typing was determined by high-performance liquid chromatography and capillary electrophoresis, and subsequently Hb variant was identified by DNA sequencing. Complete blood counts were performed using automated blood cell counter and oxygen saturation was measured by pulse oximetry.
RESULTS: Proband was compound heterozygous for Hb Louisville [β42(CD1)Phe→Leu] and Hb La Desirade [β129(H7)Ala→Val]. Of the proband's two sons, one was compound heterozygous for Hb Louisville and Hb E and the other for Hb La Desirade and Hb E. The former son had similar clinical features and laboratory findings with those of the proband while the latter showed had no abnormal clinical manifestations.
CONCLUSION: This the first report of compound heterozygosity of Hb Louisville and Hb La Desirade in an individual of Southeast Asian ethnicity. Hb variant identification is crucial for genetic counseling and appropriate treatment in regions where hemoglobinopathies are common.

Entities:  

Keywords:  Hb La Desirade; Hb Louisville; anemia; hemoglobinopathies; ineffective erythropoiesis; low oxygen saturation; pulse oximetry; thalassemia

Mesh:

Substances:

Year:  2016        PMID: 27670359     DOI: 10.1080/10245332.2016.1231989

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  1 in total

1.  Clinical and Laboratory Features of Hemoglobin La Desirade Variant in Association with Sickle Cell and Alpha Thalassemia Genes.

Authors:  S Alkindi; S Al Zadjali; M Al Rawahi; H Al Haddabi; S Daar; R A ElSadek; B D Sherkawy; A V Pathare
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-01-01       Impact factor: 2.576

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.